+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Biomaterials in Cancer Therapy. Innovations and Applications

  • Book

  • September 2026
  • Elsevier Science and Technology
  • ID: 6250901
Biomaterials in Cancer Therapy: Innovations and Applications explores the critical role of functional biomaterials in addressing one of today’s most pressing health challenges-cancer. Despite advancements in therapies, cancer continues to claim millions of lives annually, necessitating innovative approaches that integrate engineering and pharmaceutical sciences. This book highlights the potential of engineered biomaterials to enhance drug delivery, minimize side effects, and promote tissue regeneration, ultimately improving patient outcomes. The content examines cutting-edge innovations in functional biomaterials, including their applications in targeted drug delivery and immunotherapy, while emphasizing the role of nanotechnology in developing effective cancer theranostics with minimal toxicity. Targeted at academicians, physicians, and industry professionals, this book serves as a vital resource for understanding the transformative potential of functional biomaterials in oncology. By addressing real-world challenges and incorporating diverse perspectives, it inspires innovative solutions that enhance global healthcare outcomes for cancer patients.

Table of Contents

1. Introduction to Functional Biomaterials
2. Fundamentals of Functional Biomaterials in Cancer Therapy
3. Functional Biomaterials in Targeted Drug Delivery
4. Hydrogels, Cryogels, and Biopolymeric Systems
5. Functional Biomaterials in Immunotherapy
6. Theranostics of Functional Biomaterials in Cancer
7. Clinical Application and Trials of Functional Biomaterials in Cancer
8. Artificial Intelligence and Machine Learning Integration to Cancer Theranostics with Functional Biomaterials
9. Mechanobiology and Biomechanics of Functional Biomaterials
10. Biocompatibility, Biodegradability, and Regulatory Considerations in the Clinical Translation of Biomaterials
11. Challenges and Future Perspectives

Authors

Alok Raghav Gachon University, Republic of Korea. Dr. Alok Raghav, MSc, PhD, is affiliated with Gachon University in Incheon, Republic of Korea. He has over a decade of experience spanning oncology, tissue engineering, biomaterials, nanotechnology, endocrinology, and clinical trials. He serves on the editorial boards of several prestigious journals, has published dozens of papers, holds multiple patents, and has edited numerous academic books. He has also contributed chapters to various books and has received numerous international and national recognitions.